<p>The 96-h survival rate of the cefotaxime-plus-ciprofloxacin group (85%, 17/20) was significantly higher than that of the cefotaxime (0%, 0/20) or the cefotaxime-plus-minocycline groups (35%, 7/20) (<i>P</i><0.001 and <i>P = </i>0.003, respectively; log-rank test).</p
Objectives: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus...
<p>Mice were monitored for survival. Survival data are plotted on a Kaplan-Meier curve (A). Treatmen...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, given: no treatment...
<p>D23580 was cultured to late log phase and administered p.o. to 8-week-old female BALB/c mice at i...
<p>Female A/J mice were infected intranasally (IN) with 10<sup>7 </sup><i>B. anthracis</i> spores an...
<p>Bacterial counts were expressed as means ± SDs.</p><p>CFU, colony-forming unit.</p>a<p>Comparison...
<p>Mice were injected IV via the tail vein with 3.2x10<sup>2</sup> CFU of <i>S</i>. <i>Typhimurium</...
<p>Mice received 9.25/or 15% TBSA wounding to establish following four treatment groups: CI, RI, Wou...
<p>Mice were gavaged with 10<sup>9</sup> CFU of <i>S</i>. <i>Typhimurium</i> following a 4-hour fast...
<p>Six-week-old Balb/C mice were inoculated i.p. with 6.0×10<sup>8 </sup>CFU bacteria; mice survival...
<p>Groups of 12 CD1 male mice were challenged i.n. with approx. 1 × 10<sup>7</sup> CFU of the indica...
<p>Swiss Webster mice were infected i.p. with 5x10<sup>3</sup> tachyzoites of <i>T</i>. <i>gondii</i...
Experimental respiratory infections were established in mice by intranasal inoculation of Streptococ...
OBJECTIVES: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus...
<p>Survival curves for control (N = 18) and LPS pretreated mice (N = 29) following intravenous bacte...
Objectives: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus...
<p>Mice were monitored for survival. Survival data are plotted on a Kaplan-Meier curve (A). Treatmen...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, given: no treatment...
<p>D23580 was cultured to late log phase and administered p.o. to 8-week-old female BALB/c mice at i...
<p>Female A/J mice were infected intranasally (IN) with 10<sup>7 </sup><i>B. anthracis</i> spores an...
<p>Bacterial counts were expressed as means ± SDs.</p><p>CFU, colony-forming unit.</p>a<p>Comparison...
<p>Mice were injected IV via the tail vein with 3.2x10<sup>2</sup> CFU of <i>S</i>. <i>Typhimurium</...
<p>Mice received 9.25/or 15% TBSA wounding to establish following four treatment groups: CI, RI, Wou...
<p>Mice were gavaged with 10<sup>9</sup> CFU of <i>S</i>. <i>Typhimurium</i> following a 4-hour fast...
<p>Six-week-old Balb/C mice were inoculated i.p. with 6.0×10<sup>8 </sup>CFU bacteria; mice survival...
<p>Groups of 12 CD1 male mice were challenged i.n. with approx. 1 × 10<sup>7</sup> CFU of the indica...
<p>Swiss Webster mice were infected i.p. with 5x10<sup>3</sup> tachyzoites of <i>T</i>. <i>gondii</i...
Experimental respiratory infections were established in mice by intranasal inoculation of Streptococ...
OBJECTIVES: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus...
<p>Survival curves for control (N = 18) and LPS pretreated mice (N = 29) following intravenous bacte...
Objectives: The in vivo efficacy of a cefotaxime-ciprofloxacin combination against Vibrio vulnificus...
<p>Mice were monitored for survival. Survival data are plotted on a Kaplan-Meier curve (A). Treatmen...
<p>C57BL/6 mice were challenged with E.G7 and then, 7 days post tumor challenge, given: no treatment...